Nesiritide in acute decompensated heart failure

New England Journal of Medicine

Volumn 365, Issue 16, 2011, Pages 1547-

  Kramer, Daniel B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NESIRITIDE;

ACUTE HEART FAILURE; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL;

EID: 80054720189     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1109292     Document Type: Letter

References (3)

1. O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011;365:32-43. [Erratum, N Engl J Med 2011;365:773.]
2. Topol EJ. The lost decade of nesiritide. N Engl J Med 2011; 365:81-2.
3. Kesselheim AS, Fischer MA, Avorn J. The rise and fall of Natrecor for congestive heart failure: implications for drug policy. Health Aff (Millwood) 2006;25:1095-102. (Pubitemid 44188246)